Epidemiolgy:
Rachel
  • Medulloblastoma is an undifferentiated tumor believed to arise from the primitive multipotential medulloblast, embryologically located in the external granular layer of the cerebellum. It is classically identified as a primitive neuroectodermal tumor (PNET) presenting in the posterior fossa.1
Etiology:
Rachel
  • In most cases, the cause of medulloblastoma is not known.
  • In some cases, medulloblastoma is associated with certain inherited diseases, including: Li-Fraumeni syndrome, Nevoid basal cell carcinoma syndrome, and Turcot syndrome. 2
Signs & Symptoms:
Brandon
Signs and symptoms may differ from patient to patient depending on the size and location of the tumor. These symptoms inlcude:3
  • Headache (especially upon wakening)
  • Nausea/Vomiting
  • Fatigue
  • Lethargy
  • Imbalance or lack of coordination
  • Problem with writing skills
  • Neck tilt or double vision
  • Changes in personality
  • Seizures
Diagnostic Procedures:
Brandon
Some of the basic diagnostic proceudres that are used for Medulloblastomas include both Magnetic Resonance Imaging (MRI) as well as surgical biopsy to determine tumor type and grade.3
Histology:
Ashley
Medulloblastoma is a type of cerebellar tumor that is found in children and adults and stems from the cerebellar vermis. 4 The exact histologic origin isn’t clear so there are different views to describe where these tumors arise. The first opinion suggests that the tumor arises from the external granular layer of the cerebellum. 4 Precursor neurons that are found in this layer of the neurons are also found in pediatric medulloblastoma . 4 Another opinion suggests that
medulloblastomas can arise from more than 1 type of cell. 4 Studies have shown that a specific calcium-binding protein and beta-tubuline isotype found in some medulloblastoma patients isn’t found in the granular layer of cerebellum. 4 Research continues to explore the histology of these pediatric brain tumors as they are the most common malignant brain tumor in children.
Lymph node drainage:
Ashley
Because the brain doesn't contain lymph node channels, metastasis do not occur through lymphatics.5
Metastatic spread:
Amanuel
Medulloblastomas rarely metastasis outside central nervous system (CNS).6
Grading:
Amanuel
According to world health organization (WHO), medulloblastomas are classified as Grade IV central nervous system tumors.7
Staging:
Lindsey
Chang Staging System:8
T1: tumor < 3cm in diameter
T2: tumor > or = to 3cm in diameter
T3a: tumor > 3cm in diameter with extension into aqueduct of Sylvius or into the foramen of Luschka
T3b: tumor > 3cm in diameter with unequivocal extension into the brain stem
T4: tumor > 3cm in diameter with extension up past aqueduct of Sylvius or down past foramen magnum
M0: no evidence of subarachnoid or hematogenous metastasis
M1: tumor cells found in cerebrospinal fluid
M2: intracranial tumor beyond primary site
M3: gross nodular seeding in spinal subarachnoid space
M4: metastasis outside cerebrospinal axis, especially in bone marrow and bone
Radiation side effects:
Lindsey
-Growth disturbances are common; growth hormone deficiency in most long term survivors8-adverse effects may be directly related to the biologically effective dose
-Gradual onset of endocrine deficits (ex: growth hormone, thyroid-stimulating hormone, adrenocorticotropic hormone)
-Late optic neuropathy or brain necrosis in < 10% of cases of patients treated to doses > 60Gy
-Secondary malignant neoplasms
-Hyperfractionated treatments are associated with moderate acute epithelial toxicity such as otitis and radioepidermitis
-Late toxicities with high dose hyperfractionated treatments: neurocognitive deficits, hearing loss, leukoencephalopathy, diffuse microhemorrhages, dystrophic calcifications on MRI
Prognosis:
Kevin
Children who have a complete resection and the typical benign histology have a good prognosis. The prognosis for these cases is similar to adults.9
Treatments:
Kevin
Surgery is the treatment of choice. If a tumor is only partially resected, or resection is not possible, radiation therapy can be used. However, given the significant side effects of radiation on the developing brain, especially in children under three, reoperation is a preferred strategy in some reports.10
TD 5/5:
Jenn
Tissue dose associated with 5% injury rate within 5 years. (TD 5/5)11

  • Ear (Middle): Serous otitis 5000cGy
  • Ear (Vestibular): Meniere’s syndrome 6000cGy
  • Retina: Blindness 5500cGy
  • Cornea: Blindness 5000cGy
  • Lens: Blindness 500cGy
  • Salivary Glands: Xerostomia 5000cGy
  • Oral cavity and pharynx: Ulceration 6000cGy
  • Pituitary: Reduced hormone production 4500cGy
References:
  1. Chao KS, Perez CA, Brady LW. Radiation Oncology Management Decisions. 3rd ed. Philadelphia, PA: Lippincott, Williams, and Wilkins; 2011: 719.
  2. Medulloblastoma. Boston Children's Hospital. http://www.childrenshospital.org/az/Site1286/mainpageS1286P1.html. Accessed July 5, 2013.
  3. Medulloblastoma. Boston Children's Hospital. http://www.childrenshospital.org/az/Site1286/mainpageS1286P0.html. Accessed July 3, 2013.
  4. MacDonald T, Coppes M, et al. Pediatric Medulloblastoma. Medscape Web site. http://reference.medscape.com/article/987886-overview#a0104. Updated March 1, 2012. Accessed June 29 2013.
  5. Chao KS, Perez CA, Brady LW. Radiation Oncology Management Decisions. 3rd ed. Philadelphia, PA: Lippincott, Williams, and Wilkins; 2011.
  6. Brain tumor FQA. National brain society. http://www.braintumor.org/patients-family-friends/about-brain-tumors/brain-tumor-faq.html#q2425. Accessed July, 2013.
  7. Meddulloblastoma. http://radiopaedia.org/articles/medulloblastoma. Accessed July 1, 2013
  8. Chao KS, Perez CA, Brady LW. Radiation Oncology Management Decisions. 3rd ed. Philadelphia, PA: Lippincott, Williams, and Wilkins; 2011: 721, 733.
  9. Mehta N, Bhagwati S, Parulekar G. Meningiomas in children: A study of 18 cases. J Pediatr Neurosci. 2009;4(2):61-65.
  10. Lenhard RE, Osteen R, Gansler T. The American Cancer Society’s Clinical Oncology. Williston, VT: Blackwell Publishing, Inc; 2001.
  11. Washington C, Leaver D. Principles and Practice of Radiation Oncology. 3rd ed. St. Louis, MO. Mosby Elsevier; 2010: 80-82.

Back to Week 6